Brazil – Class II Medical Devices – New Resolution
A new Resolution of the Collegiate Board of Directors (RDC No. 423/2020) has been published by Brazil’s National Agency of Health Surveillance (ANVISA). This new Resolution announces the elimination of the ‘Cadastro’ pathway regarding the registration of medical devices (Class II) and IVDs, substituting it with a notification registration system.
Liliana Teles

Liliana Teles

Regulatory Affairs Manager

MEDICAL DEVICES LEGAL FRAMEWORK IN BRAZIL

Medical devices placed in the Brazilian market must be registered at Brazil’s National Agency of Health Surveillance (ANVISA), in accordance with the Brazilian Resolution RDC. No. 185. Manufacturers or importers of such products need to submit to ANVISA all the documents required for their registration as well as for their alteration, revalidation or cancellation. After evaluating all the documentation for registration, alteration, revalidation or cancellation, ANVISA publishes its decision on the Brazilian Official Gazette (DOU).

According to the risk they represent to consumers, patients, operators or third parties involved, medical products are classified as Class I, II, III or IV. In case of doubts in the classification, ANVISA is the one classifying the medical device.

Until recently, Class II medical devices were subject to a short registration process called ‘Cadastro’ (pre-market approval). Manufacturers of Class II medical devices (and some Class I) were requested to provide technical dossiers, labelling materials and proposed indications of use (IFU) documents to their Brazilian Registration Holder (BRH) representative in the country.

NEW RESOLUTION ON MEDICAL DEVICES CLASS II

According to the new Resolution published in September 2020, as it happens with Class I medical devices, Class II devices only require a formal notification (‘Notificação’) and no longer need an approval by ANVISA before entering the market. This notification shall be done using a special form available at ANVISA’s website. Now, manufacturers do not need to submit a technical dossier but should have these documentation available upon request (in case of an inspection by ANVISA). The main goal of the new Resolution is to help ANVISA to focus on high-risk medical products.

IVDs (Class I and II) may now also enter the Brazilian market via the notification pathway.

Class II medical devices that are already registered in ANVISA do not require a re-validation (except if changes are requested).

References:

  1. Resolução da Diretoria Colegiada – RDC Nº 423, de 16 se Setembro 2020. Available at: https://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?data=18/09/2020&jornal=515&pagina=110&totalArquivos=139
  2. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolution RDC No. 185, of October 22nd, 2001. Available at: https://www.emergobyul.com/sites/default/files/file/rdc_185_2001_classification_and_registration_requirements_of_medical_products_0.pdf
  3. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 270, de 28 de Fevereiro de 2019. Available at: http://rapassarini.com.br/wp-content/uploads/2019/03/RESOLUC%CC%A7A%CC%83O-DA-DIRETORIA-COLEGIADA-RDC-N%C2%BA-270-DE-28-DE-FEVEREIRO-DE-2019-Dia%CC%81rio-Oficial-da-Unia%CC%83o-Imprensa-Nacional.pdf
  4. Ministério da Saúde, Agência Nacional de Vigilância Sanitária (ANVISA) – Resolução da Diretoria Colegiada – RDC Nº 27, de 21 de Junho de 2011. Available at: http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2011/rdc0027_21_06_2011.pdf

further
reading

cosmetic products

New Formaldehyde Threshold in Cosmetic Products

The European Commission has issued a draft regulation to amend the preamble of Annex V regarding the threshold for labelling formaldehyde releasers. This amendment results from a scientific advice published by the SCCS concluding that the current threshold does not sufficiently protect consumers sensitized to formaldehyde.

Read More »
cosmetic products

New Restriction on the Use of Benzophenone-3 in Cosmetics

Benzophenone-3 was part of a priority list of potential endocrine disruptors established by the European Commission in 2019. The SCCS was asked to assess the safety of this ingredient and the European Cosmetics Regulation will be amended in accordance with the SCCS assessment conclusions.

Read More »
endocrine disruptors
cosmetic products

European Commission Calls for Data on Ingredients with Potential Endocrine-Disrupting Properties

Substances classified as endocrine disruptors are compounds that can alter the functioning of the endocrine system and negatively affect the health of humans and animals. In 2019, the European Commission set out two lists of ingredients suspected of having endocrine disrupting properties. More recently, the Commission has published a call for data for 10 ingredients that were included in the low priority group (Group B) for the SCCS to be able to assess their safety.

Read More »
cosmetic products

SCCS Preliminary Opinion on Prostaglandins and Prostaglandin-analogues

Following the mandate from the European Commission, the Scientific Committee on Consumer Safety (SCCS) has published a preliminary opinion on Prostaglandins and Prostaglandin-analogues used in cosmetic products. This preliminary opinion is open for comments and the deadline was set for 23 november 2021.

Read More »
cosmetic products

SCCS Preliminary Opinion on Butylated Hydroxytoluene (BHT)

Following the mandate from the European Commission, the Scientific Committee on Consumer Safety (SCCS) has published a preliminary opinion on Butylated Hydroxytoluene (BHT). This preliminary opinion is open for comments and the deadline was set for 23 november 2021.

Read More »
cosmetic products

EU Prohibition of Zinc Pyrithione in Cosmetic Products

Zinc Pyrithione has been used for more than 60 years as an anti-dandruff agent in cosmetic products. Last month, the European Commission published the Commission Regulation (EU) 2021/1092, which includes this ingredient in Annex II. From March 2022 onwards, Zinc Pyrithione will be prohibited in cosmetic products.

Read More »
medical devices

EUDAMED Status Update 2021

The development and deployment of EUDAMED is progressing. Following the implementation plan and getting familiar with the information stored in the database’s modules is crucial for economic operators compliance in the EU market.

Read More »
cosmetic products

EU Chemicals Strategy for Sustainability

The Chemicals Strategy for Sustainability (CSS) was recently published by the European Union. The CSS is part of the European Green Deal which aims for a toxic-free environment leading to zero pollution. The initiative proposes a new legislative amend to the EU Cosmetic Products Regulation. Simplification and digitalization of labelling requirements plus review of the definition of nanomaterial are two of the main objectives of the CSS.

Read More »
cosmetic products

Nanotechnology in Sun Care Products

Nanomaterials are increasingly used in cosmetics and personal care products. They are similar to other chemicals/substances, but with specific risks associated to their use. Currently, there are 4 nano-ingredients approved in the European Union for use as UV filters in cosmetic products.

Read More »
cosmetic products

May Butylphenyl Methylpropional be used in Cosmetic Products?

Butylphenyl Methylpropional, also known as Lilial, is a fragrance ingredient that has been used for years in several cosmetic and non-cosmetic products. Nevertheless, some concerns have been expressed regarding the use of this ingredient and its risk to consumers. According to an amendment to the CLP Regulation, the use of Butylphenyl Methylpropional will be prohibited in cosmetic products from 1st March 2022.

Read More »
cosmetic products

How are Cosmetic Products Regulated in the United Arab Emirates?

The United Arab Emirates (UAE) are an emerging market for the beauty industry. Cosmetics and personal care products supplied or sold in the UAE must comply with the health and safety requirements set out in UAE legislation. Overall, the process for importing a cosmetic product into the UAE market from the European Union can be quite straightforward since the UAE has aligned several of its requirements with the European Cosmetic Regulation.

Read More »